NL

Nimmala Lingaswamy

Active Director Managing Director DIN 11568282
DIN 11568282 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Nimmala Lingaswamy

Data last updated:

Nimmala Lingaswamy is a Managing Director at Zoevita Pharmaceuticals Private Limited (since 2026). The company operates in Pharma.

DIN 11568282
Primary Designation Managing Director
Industry Pharma
First Appointment 24 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director24 Feb 20262026Active

Board colleagues of Nimmala Lingaswamy

NameDINCompanyDesignation
Nimmala Swathi11568281Zoevita Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Zoevita Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Nimmala Lingaswamy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nimmala Lingaswamy

Nimmala Lingaswamy currently holds 1 directorship: Zoevita Pharmaceuticals Private Limited (Managing Director, since 24 Feb 2026).

Nimmala Lingaswamy was first appointed on 24 Feb 2026 as Managing Director at Zoevita Pharmaceuticals Private Limited.

The current boards of Nimmala Lingaswamy's companies include Nimmala Swathi (Zoevita Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available